Noninvasive Detection of Testicular Carcinoma In Situ in Semen Using OCT3/4

European Urology

Volumn 54, Issue 1, 2008, Pages 153-160

  van Casteren, Niels J ^a   Stoop, Hans ^b   Dohle, Gert R ^a   de Wit, Ronald ^a   Oosterhuis, J Wolter ^b   Looijenga, Leendert H J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Carcinoma in situ; Early diagnosis; Exfoliation; OCT3 4; Testicular cancer

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CARCINOMA IN SITU; CLINICAL ARTICLE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEYDIG CELL TUMOR; MALE; MIXED TUMOR; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; SCROTUM; SEMEN ANALYSIS; SEMINOMA; SERTOLI CELL TUMOR; STONE FORMATION; TESTIS BIOPSY; TESTIS CARCINOMA; TESTIS CARCINOMA IN SITU; TESTIS DISEASE; TESTIS MICROLITHIASIS; TESTIS TUMOR; TUMOR BIOPSY;

ADULT; BIOPSY; CARCINOMA IN SITU; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MASS SCREENING; NEOPLASMS, GERM CELL AND EMBRYONAL; OCTAMER TRANSCRIPTION FACTOR-3; ORCHIECTOMY; PILOT PROJECTS; SEMEN; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 44049103626     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.10.042     Document Type: Article

References (36)

1. Oosterhuis J.W., and Looijenga L.H. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5 (2005) 210-222
2. Huyghe E., Matsuda T., and Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 170 (2003) 5-11
3. Maffezzini M. TC incidence increasing: spread the word. Eur Urol 51 (2007) 596-597
4. Huyghe E., Plante P., and Thonneau P.F. Testicular cancer variations in time and space in Europe. Eur Urol 51 (2007) 621-628
5. Post P.N., Casparie M.K., Kate F.J.W., and ten en Oosterhuis J.W. Epidemiologie van testistumoren in Nederland: accurate weergave in de PALGA-registratie. Nederlands tijdschrift voor Geneeskunde 148 (2004) 1150-1154
6. Hoei-Hansen C.E., Rajpert-De Meyts E., Daugaard G., and Skakkebaek N.E. Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol 16 (2005) 863-868
7. Looijenga L.H., and Oosterhuis J.W. Pathobiology of testicular germ cell tumors: views and news. Anal Quant Cytol Histol 24 (2002) 263-279
8. Honecker F., Stoop H., de Krijger R.R., et al. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 203 (2004) 849-857
9. Rorth M., Rajpert-De Meyts E., Andersson L., et al. Carcinoma in situ in the testis. Scand J Urol Nephrol Suppl 205 (2000) 166-186
10. Oosterhuis J.W., Kersemaekers A.M., Jacobsen G.K., et al. Morphology of testicular parenchyma adjacent to germ cell tumours. An interim report. Apmis 111 (2003) 32-40 discussion 1-2
11. Perry A., Wiley E.L., and Albores-Saavedra J. Pagetoid spread of intratubular germ cell neoplasia into rete testis: a morphologic and histochemical study of 100 orchiectomy specimens with invasive germ cell tumors. Hum Pathol 25 (1994) 235-239
12. de Gouveia Brazao C.A., Pierik F.H., Oosterhuis J.W., et al. Bilateral testicular microlithiasis predicts the presence of the precursor of testicular germ cell tumors in subfertile men. J Urol 171 (2004) 158-160
13. Dieckmann K.P., and Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 22 (2004) 2-14
14. Dieckmann K.P., and Skakkebaek N.E. Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer 83 (1999) 815-822
15. Dieckmann K.P., Besserer A., and Loy V. Low-dose radiation therapy for testicular intraepithelial neoplasia. J Cancer Res Clin Oncol 119 (1993) 355-359
16. Giwercman A., von der Maase H., Berthelsen J.G., et al. Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 73 (1991) 596-603
17. Czaplicki M., Rojewska J., Pykalo R., and Szymanska K. Detection of testicular neoplasms by cytological examination of seminal fluid. J Urol 138 (1987) 787-788
18. Giwercman A., Marks A., and Skakkebaek N.E. Carcinoma-in-situ germ-cells exfoliated from seminiferous epithelium into seminal fluid. Lancet 1 (1988) 530
19. Meng F.J., Zhou Y., Giwercman A., et al. Fluorescence in situ hybridization analysis of chromosome 12 anomalies in semen cells from patients with carcinoma in situ of the testis. J Pathol 186 (1998) 235-239
20. Hoei-Hansen C.E., Rajpert-De Meyts E., Carlsen E., et al. A subfertile patient diagnosed with testicular carcinoma in situ by immunocytological staining for AP-2gamma in semen samples: case report. Hum Reprod 20 (2005) 579-582
21. Brackenbury E.T., Grigor K.M., McIntyre M.A., Howard G.C., and Hargreave T.B. Negative testicular biopsy and asynchronous bilateral testicular germ cell tumour. Eur Urol 25 (1994) 79-81
22. Hoei-Hansen C.E., Carlsen E., Jorgensen N., et al. Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers. Hum Reprod 22 (2007) 167-173
23. Meng F.J., Zhou Y., Skakkebaek N.E., Marks A., and Giwercman A. Detection and enrichment of carcinoma-in-situ cells in semen by an immunomagnetic method using monoclonal antibody M2A. Int J Androl 19 (1996) 365-370
24. Looijenga L.H., Stoop H., de Leeuw H.P., et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63 (2003) 2244-2250
25. de Jong J., Stoop H., Dohle G.R., et al. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol 206 (2005) 242-249
26. de Jong J., and Looijenga L.H. Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit Rev Oncog 12 (2006) 171-203
27. Andrews P.W., Damjanov I., Simon D., et al. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 50 (1984) 147-162
28. Giwercman A., Cantell L., and Marks A. Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F. Apmis 99 (1991) 586-594
29. Dieckmann K.-P., Kulejewski M., Pichlmeier U., and Loy V. Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy. Eur Urol 51 (2007) 175-185
30. van Casteren N.J., Boellaard W.P.A., Dohle G.R., et al. Heterogeneous distribution of ITGCNU in an adult testis; consequences for biopsy-based diagnosis. Int J Surg Pathol 16 (2008) 21-24
31. Giwercman A., Hopman A.H., Ramaekers F.C., and Skakkebaek N.E. Carcinoma in situ of the testis. Detection of malignant germ cells in seminal fluid by means of in situ hybridization. Am J Pathol 136 (1990) 497-502
32. Giwercman A., Muller J., and Skakkebaek N.E. Prevalence of carcinoma in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 145 (1991) 77-80
33. Schutte B., Holstein A.F., and Schirren C. Macrophages lysing seminoma cells in patients with carcinoma-in-situ (CIS) of the testis. Andrologia 20 (1988) 295-303
34. Kollmannsberger C., Kuzcyk M., Mayer F., et al. Late toxicity following curative treatment of testicular cancer. Semin Surg Oncol 17 (1999) 275-281
35. Daugaard G., Giwercman A., and Skakkebaek N.E. Should the other testis be biopsied?. Semin Urol Oncol 14 (1996) 8-12
36. Raman J.D., Nobert C.F., and Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol 174 (2005) 1819-1822 discussion 22